Prof Peter Revill

Medical Scientist focused on the molecular virology for the hepatitis B virus (HBV)

I have dedicated my working life to fast tracking a cure for chronic hepatitis B and eliminating stigma associated with living with viral hepatitis.

I am co-founder and Chair of the Governing Board of the International Coalition to Eliminate Hepatitis B (ICE-HBV). I also lead a research group dedicated to understanding how HBV causes liver cancer, and develop new approaches to cure HBV infection.

I have been researching hepatitis B virus in my capacity as a scientist at Melbourne Health for over 15 years.

In 2016, with colleagues from Melbourne Health, the ANRS in France, and the International HBV meeting, we formed the International Coalition to Eliminate HBV (ICE-HBV), which is coordinating global research efforts to fast track HBV cure.

There are 257 million people worldwide living with chronic HBV, including 221,000 Australians and while there are effective therapies, treatment is daily, long term, and does not eliminate the risk of liver cancer.

HBV causes 40% of all liver cancers, and as
the highly effective preventative vaccine has no impact on existing infections,
a cure is urgently required.